Page last updated: 2024-08-25

ketorolac tromethamine and Ovarian Neoplasms

ketorolac tromethamine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, SF; Bedrick, E; Cook, L; Guo, Y; Hudson, LG; Kang, H; Kenney, SR; Lomo, L; Muller, CY; Oprea, TI; Romero, E; Rutledge, T; Sklar, LA; Wandinger-Ness, A; Wiggins, CL	1

Trials

1 trial(s) available for ketorolac tromethamine and Ovarian Neoplasms

Article	Year
A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Nov-15, Volume: 21, Issue:22 Topics: Aged; cdc42 GTP-Binding Protein; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Ketorolac; Ketorolac Tromethamine; Middle Aged; Ovarian Neoplasms; Paclitaxel; rac1 GTP-Binding Protein	2015

Article

Year

A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Nov-15, Volume: 21, Issue:22

Topics: Aged; cdc42 GTP-Binding Protein; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Ketorolac; Ketorolac Tromethamine; Middle Aged; Ovarian Neoplasms; Paclitaxel; rac1 GTP-Binding Protein

2015